These either “extra” or “overactive” Hsp90 proteins are thought to act as chaperones to stabilize many oncoproteins inside the tumour cells and, therefore, have triggered excitement for development of Hsp90 inhibitors as anti-cancer therapeutics11, 12, 15. The gene discussed is HSP90AA1; the disease is neoplasm.